D-Dimer Levels in Covid-19 Patients with Moderate and Severe Symptoms

Manalu, Erida and Josafat, Jonathan and Luhulima, Danny Ernest Jonas (2023) D-Dimer Levels in Covid-19 Patients with Moderate and Severe Symptoms. International Journal of Health Sciences and Research, 13 (2). pp. 210-216. ISSN 2249-9571

	Text DDimerLevelsinCovid19.pdf Download (187kB)
	Text (Hasil_Turnitin) TurnitinDDimerLevelsinCovid19.pdf Download (2MB)

Abstract

COVID-19 is an infectious disease in humans. This disease is caused by a new virus similar to SARS- CoV, called SARS-CoV-2. This virus attacks the human respiratory system and causes symptoms such as cough, fever above 38°C, shortness of breath, muscle aches, malaise, and diarrhea. Elevated levels of D-Dimer are often found in patients with severe COVID-19 symptoms. Previous studies have shown that increased levels of D-Dimer can increase the risk of death and is also a marker of poor prognosis. The purpose of this study was to provide an overview of D-Dimer levels in patients confirmed by COVID-19 with moderate and severe symptoms at UKI General Hospital. This study is a cross- sectional study with descriptive and analytic data presentation from the Medical Record document of UKI General Hospital. Data that has been collected was processed using the Mann-Whitney test. The subjects of this study are 211 patients who were confirmed to have COVID-19 through RT-PCR examination and had checked for D-Dimer levels. The Mann-Whitney test that was carried out gave a p-value <0.05, which means a significant difference in the mean D-Dimer level between COVID-19 patients with moderate and severe symptoms. The average level of D-Dimer in moderate symptoms was 441.272 ng/mL with 154 patients. The average level of D-Dimer in severe symptoms is 1,231,630 ng/mL with 57 patients. Key words: D-Dimer, COVID-19, mild symptoms, severe symptoms

Actions (login required)

View Item